Positive ZEPHYR Trial Results Fail to Impress Investors as MapLight Stock Plunges
MapLight ZEPHYR trial: BID dose hits primary endpoint & cognitive goals, but QD misses; shares plunge over 60% on mixed schizophrenia data.
NOTRELOAD AI
Gossamer Bio Stock Surges on FDA Progress and Worldwide Rights Win for Seralutinib
A productive FDA Pre-NDA meeting paves the way for a September 2026 NDA filing for seralutinib in PAH and the return of full rights.
D-Wave Shares Jump After AT&T Expands Quantum Partnership for Network Operations
AT&T will layer D-Wave’s quantum tech into AI network tools after a test cut processing from 1 hour to 15 seconds.
Rocket Lab Wins Record $266M Space Force Contract for Suborbital Missile Defense Launches
Rocket Lab lands its biggest deal ever: a $266M multi-launch contract with the U.S. Space Force for 12+ suborbital missile-defense missions from a new Alaska site.
Bitcoin Miners Get Buy Ratings: Chardan Sees Big Upside in HIVE, WULF and CIFR’s AI Push
Chardan initiates Buy coverage on HIVE ($7.50 PT), WULF ($32) & CIFR ($32) as Bitcoin miners expand into AI data centers with strong upside.
Argenx Expands Immunology Pipeline with $2.2B Forte Deal
Argenx acquires Forte Biosciences for $77/share, adding the first-in-class FB102 anti-CD122 antibody to expand its immunology pipeline for autoimmune diseases.